DMT310-009 Topical in the Treatment of Acne Vulgaris
Trial details
- Registry ID
- NCT06090721
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| DMT310-009 Topical in the Treatment of Acne VulgarisNCT06090721 | Dermata Therapeutics | Phase 3 | Completed | 2025-03-31Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |